Related Experiment Video
Updated: Apr 26, 2026
Y-90 Radioembolization and PD-1 Inhibitor as Neoadjuvant Treatment in Hepatocellular Carcinoma
Published on: May 24, 2024
Effects of SSd combined with radiation on inhibiting SMMC-7721 hepatoma cell growth
Bao-Feng Wang1, Shuai Lin1, Ming Hua Bai1
1Department of Oncology, Second Affiliated Hospital of Medical School, Xi'an Jiaotong University, Xi'an, China (mainland).
Background:
The aim of this study was to investigate the effects of Saikosaponin-d (SSd) combined with radiotherapy on SMMC-7721 hepatoma cell lines and its mechanism.
Material/Methods:
SMMC-7721 hepatoma cell lines are selected in our research. With MTT (methylthiazolyldiphenyl-tetrazolium-bromide) method, the effects of SSd and radiation on inhibiting SMMC-7721 cell growth were investigated. We also used transmission electron microscopy (TEM) to observe ultrastructural changes of cells. Colorimetry methods were used to measure content changes of glutathione (GSH) and malondialdehyde (MDA) in cells.
Results:
Both SSd and radiation inhibited the growth of SMMC-7721 cells. The combination of SSd and radiotherapy had a time-dependent synergistic effect. Radiation caused ultrastructural damage to cells, and the damage was enhanced in combination with SSd. Radiation decreased the GSH content and increased the MDA content in cells, and this effect was suppressed after the intervention of SSd.
Conclusions:
SSd can inhibit the growth of SMMC-7721 hepatoma cell lines in vitro. Additionally, it significantly enhances the effects of radiation on inhibiting the growth of SMMC-7721 hepatoma cell lines, and up-regulates the antioxidant level after the radiotherapy. Thus, SSd could be an ideal radiotherapy sensitizer for the treatment of liver cancer.
Insights
Saikosaponin-d (SSd) enhances radiotherapy's cancer-fighting effects on liver cells. This compound inhibits hepatoma cell growth and boosts the body's antioxidant defenses post-treatment, suggesting its potential as a radiotherapy sensitizer.
Area of Science:
- Hepatocellular Carcinoma Research
- Radiotherapy Sensitization
- Natural Product Pharmacology
Background:
- Hepatocellular carcinoma (HCC) remains a significant global health challenge.
- Investigating novel therapeutic strategies to improve radiotherapy efficacy is crucial.
- Saikosaponin-d (SSd) is a compound with potential anti-cancer properties.
Purpose of the Study:
- To evaluate the combined effects of Saikosaponin-d (SSd) and radiotherapy on SMMC-7721 hepatoma cell lines.
- To elucidate the underlying mechanisms of SSd in sensitizing cells to radiotherapy.
- To assess SSd's impact on cellular oxidative stress markers.
Main Methods:
- SMMC-7721 hepatoma cell lines were utilized.
- MTT assay was employed to determine cell viability and growth inhibition.
- Transmission electron microscopy (TEM) was used for ultrastructural analysis.
- Colorimetric methods quantified glutathione (GSH) and malondialdehyde (MDA) levels.
Main Results:
- Both SSd and radiotherapy individually inhibited hepatoma cell growth.
- A time-dependent synergistic effect was observed when SSd was combined with radiotherapy.
- SSd enhanced radiation-induced ultrastructural damage to cancer cells.
- SSd intervention mitigated the decrease in GSH and increase in MDA caused by radiation.
Conclusions:
- Saikosaponin-d (SSd) demonstrates in vitro inhibitory effects on SMMC-7721 hepatoma cell growth.
- SSd significantly potentiates the anti-proliferative effects of radiotherapy on liver cancer cells.
- SSd up-regulates the antioxidant system following radiotherapy, suggesting its potential as a radiotherapy sensitizer for liver cancer treatment.
